Loading...
Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data
BACKGROUND: Esophageal adenocarcinoma has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett esophagus, a precursor of esophageal adenocarcinoma. Randomised controlled trial data from the BEST3 trial has shown that an offer of Cyt...
Na minha lista:
| Udgivet i: | EClinicalMedicine |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8225801/ https://ncbi.nlm.nih.gov/pubmed/34195582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100969 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|